189 related articles for article (PubMed ID: 27129144)
1. Crystals and tablets in the Spanish ecstasy market 2000-2014: Are they the same or different in terms of purity and adulteration?
Vidal Giné C; Ventura Vilamala M; Fornís Espinosa I; Gil Lladanosa C; Calzada Álvarez N; Fitó Fruitós A; Rodríguez Rodríguez J; Domíngo Salvany A; de la Torre Fornell R
Forensic Sci Int; 2016 Jun; 263():164-168. PubMed ID: 27129144
[TBL] [Abstract][Full Text] [Related]
2. The variability of ecstasy tablets composition in Brazil.
Togni LR; Lanaro R; Resende RR; Costa JL
J Forensic Sci; 2015 Jan; 60(1):147-51. PubMed ID: 25125149
[TBL] [Abstract][Full Text] [Related]
3. Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands.
van der Gouwe D; Brunt TM; van Laar M; van der Pol P
Addiction; 2017 Apr; 112(4):640-648. PubMed ID: 27936283
[TBL] [Abstract][Full Text] [Related]
4. Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity.
Parrott AC
Psychopharmacology (Berl); 2004 May; 173(3-4):234-41. PubMed ID: 15007594
[TBL] [Abstract][Full Text] [Related]
5. Residual solvents in methylenedioxymethamphetamine tablets as a source of strategic information and as a tool for comparative analysis: the development and application of a static headspace gas chromatography/mass spectrometry method.
Visser HA; Visser-van Leeuwen M; Huizer H
Bull Narc; 2005; 57(1-2):167-82. PubMed ID: 21338020
[TBL] [Abstract][Full Text] [Related]
6. Content of ecstasy in the Netherlands: 1993-2008.
Vogels N; Brunt TM; Rigter S; van Dijk P; Vervaeke H; Niesink RJ
Addiction; 2009 Dec; 104(12):2057-66. PubMed ID: 19804461
[TBL] [Abstract][Full Text] [Related]
7. Variability in the 3,4-methylenedioxymethamphetamine content of 'ecstasy' tablets in the UK.
Wood DM; Stribley V; Dargan PI; Davies S; Holt DW; Ramsey J
Emerg Med J; 2011 Sep; 28(9):764-5. PubMed ID: 20724467
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological content of tablets sold as "ecstasy": results from an online testing service.
Tanner-Smith EE
Drug Alcohol Depend; 2006 Jul; 83(3):247-54. PubMed ID: 16364567
[TBL] [Abstract][Full Text] [Related]
9. Chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in Hong Kong.
Cheng WC; Poon NL; Chan MF
J Forensic Sci; 2003 Nov; 48(6):1249-59. PubMed ID: 14640267
[TBL] [Abstract][Full Text] [Related]
10. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA).
Kalasinsky KS; Hugel J; Kish SJ
J Forensic Sci; 2004 Sep; 49(5):1106-12. PubMed ID: 15461119
[TBL] [Abstract][Full Text] [Related]
11. mCPP: an undesired addition to the ecstasy market.
Bossong MG; Brunt TM; Van Dijk JP; Rigter SM; Hoek J; Goldschmidt HM; Niesink RJ
J Psychopharmacol; 2010 Sep; 24(9):1395-401. PubMed ID: 19304863
[TBL] [Abstract][Full Text] [Related]
12. Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project.
Brunt TM; Nagy C; Bücheli A; Martins D; Ugarte M; Beduwe C; Ventura Vilamala M
Drug Test Anal; 2017 Feb; 9(2):188-198. PubMed ID: 26888408
[TBL] [Abstract][Full Text] [Related]
13. Fingerprinting of 3, 4-methylenedioxymethamphetamine markers by desorption/ionization on porous silicon.
Kraj A; Swist M; Strugała A; Parczewski A; Silberring J
Eur J Mass Spectrom (Chichester); 2006; 12(4):253-9. PubMed ID: 17057282
[TBL] [Abstract][Full Text] [Related]
14. Combining attenuated total reflectance- infrared spectroscopy and chemometrics for the identification and the dosage estimation of MDMA tablets.
Deconinck E; Van Campenhout R; Aouadi C; Canfyn M; Bothy JL; Gremeaux L; Blanckaert P; Courselle P
Talanta; 2019 Apr; 195():142-151. PubMed ID: 30625524
[TBL] [Abstract][Full Text] [Related]
15. Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department.
Sherlock K; Wolff K; Hay AW; Conner M
J Accid Emerg Med; 1999 May; 16(3):194-7. PubMed ID: 10353046
[TBL] [Abstract][Full Text] [Related]
16. Instability of the ecstasy market and a new kid on the block: mephedrone.
Brunt TM; Poortman A; Niesink RJ; van den Brink W
J Psychopharmacol; 2011 Nov; 25(11):1543-7. PubMed ID: 20826554
[TBL] [Abstract][Full Text] [Related]
17. Composition profiling of seized ecstasy tablets by Raman spectroscopy.
Bell SE; Burns DT; Dennis AC; Matchett LJ; Speers JS
Analyst; 2000 Oct; 125(10):1811-5. PubMed ID: 11070550
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of reagent test-kit use and perceptions of purity among ecstasy users in an electronic dance music scene in New York City.
Palamar JJ; Barratt MJ
Drug Alcohol Rev; 2019 Jan; 38(1):42-49. PubMed ID: 30575155
[TBL] [Abstract][Full Text] [Related]
19. Is online information on ecstasy tablet content safe?
Vrolijk RQ; Brunt TM; Vreeker A; Niesink RJ
Addiction; 2017 Jan; 112(1):94-100. PubMed ID: 27518128
[TBL] [Abstract][Full Text] [Related]
20. [Ecstasy--the status in French-speaking Switzerland. Composition of seized drugs, analysis of biological specimens and short review of its pharmacological action and toxicity].
Giroud C; Augsburger M; Sadeghipour F; Varesio E; Veuthey JL; Rivier L
Praxis (Bern 1994); 1997 Mar; 86(13):510-23. PubMed ID: 9157497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
